Articles Related to Zhao Y
Pharmacy Compounding Quality Control and Pharmaceutical Development Strategies for Seventeen alpha Hydroxyprogesterone Caproate in Prevention of Preterm Delivery
Seventeen alpha hydroxyprogesterone caproate (17-OHPC) is the only FDA-approved drug labeled for prevention of preterm delivery. This drug is also available as a compounded product from licensed compounding pharmacies. This article reviews the FDA approval history and pharmacy compounding quality control data of 17-OHPC, as well as briefly discusses possible future pharmaceutical development strategies for 17-OHPC.
A new method for improvement of 1,2-indandione-treated latent fingermarks on thermal paper will be described in this paper. Treatment with conventional techniques like ninhydrin in petroleum ether or DFO solution produces a black color on the thermosensitive side of thermal paper.